Pharmafile Logo
Pharmafocus logo
Advanced Search
incyte_headshot

Peter Williams

November 29, 2022
Business Services

Incyte has announced its appointment of Peter Williams as General Manager for the UK and Ireland division. His new role …

Appointment

University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery

November 29, 2022
Research and Development

Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …

News

AstraZeneca to acquire Neogene for up to $320m

November 29, 2022
Sales and Marketing

AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …

News

Full-Life Technologies to acquire Focus-X Therapeutics

November 29, 2022
Sales and Marketing

Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.  

News

Siemens Healthineers and Atrium Health team up in $140m deal

November 29, 2022
Sales and Marketing

Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …

News

Scott Curley

November 28, 2022
Business Services

Following a positive NICE recommendation for VAZKEPA® (icosapent ethyl), which has allowed Amarin to continue with its commercial expansion, Amarin …

Appointment

Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA

November 28, 2022
Medical Communications

NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …

News

Brainomix and Pixyl partner to offer multiple sclerosis treatment

November 28, 2022
Medical Communications

In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …

News

C4X Discovery signs licensing deal worth up to $402m with AstraZeneca

November 28, 2022
Sales and Marketing

Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …

News

Two-dose chemotherapy drug enters clinical trial for cancer patients

November 28, 2022
Research and Development

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …

News

NHS nurses strike announced for 15 and 20 December

November 25, 2022
Medical Communications

The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …

News

NICE recommends new life-extending treatment for rare form of gastroesophageal cancer

November 25, 2022
Medical Communications

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …

News

The University of Bristol trial to test rapid checks for reduction of antibiotic prescriptions

November 24, 2022
Business Services

The University of Bristol has begun a trial to see if the rapid testing of initial symptoms could cut the number …

News

Iveda reveals AI-driven caregiver assistant, IvedaCare

November 24, 2022
Business Services

Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they …

News
dr-frank-mathias

Dr Frank Mathias

November 23, 2022

Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his …

Appointment

Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue

November 23, 2022
Sales and Marketing

Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …

News

Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution

November 23, 2022
Research and Development

Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …

News

Haemophilia drug costing $3.5m per dose has been approved

November 23, 2022
Sales and Marketing

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price …

News

SMC accepts HRT treatment Bijuve for use across NHS Scotland

September 13, 2022
Manufacturing and Production

The SMC has accepted HRT treatment, Bijuve, for use across NHS Scotland. Bijuve is the first and only body-identical HRT …

News

New malaria vaccine demonstrates high efficacy

September 9, 2022
Medical Communications

  A new malaria vaccine could be pivotal in the fight against the deadly disease. This vaccine has been developed …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026